カテゴリー： Market Monitor Global, 世界, 医療/バイオ

抗ニューロピリン-1抗体の世界市場見通し2023年-2029年

◆英語タイトル：Anti-Neuropilin-1 Antibody Market, Global Outlook and Forecast 2023-2029

Market Monitor Globalが発行した調査報告書（MMG23FB2458）◆商品コード：MMG23FB2458
◆発行会社（リサーチ会社）：Market Monitor Global
◆発行日：2023年2月
◆ページ数：75
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後2-3営業日）
◆調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
◆産業分野：医薬品
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,250 ⇒換算￥494,000見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD4,225 ⇒換算￥642,200見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）USD4,875 ⇒換算￥741,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

当調査レポートは次の情報を含め、世界の抗ニューロピリン-1抗体市場規模と予測を収録しています。・世界の抗ニューロピリン-1抗体市場：売上、2018年-2023年、2024年-2029年
・世界の抗ニューロピリン-1抗体市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の抗ニューロピリン-1抗体市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「モノクローナル抗体」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。

抗ニューロピリン-1抗体のグローバル主要企業は、LifeSpan BioSciences, Inc、Thermo Fisher、RayBiotech, Inc.、MyBiosource, Inc.、Shanghai Korain Biotech Co., Ltd.、Wuhan Fine Biotech Co., Ltd.、CUSABIO、Boster Biological Technology、Biomatik、Assay Genie、Abbexa、CLOUD-CLONE CORP.、Innovative Research、ZodelBiotec Ltd.などです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

MARKET MONITOR GLOBAL（MMG）は、抗ニューロピリン-1抗体のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別市場分析】

世界の抗ニューロピリン-1抗体市場：タイプ別、2018年-2023年、2024年-2029年
世界の抗ニューロピリン-1抗体市場：タイプ別市場シェア、2022年
・モノクローナル抗体、ポリクローナル抗体

世界の抗ニューロピリン-1抗体市場：用途別、2018年-2023年、2024年-2029年
世界の抗ニューロピリン-1抗体市場：用途別市場シェア、2022年
・フローサイトメトリー、ELISA、ウエスタンブロット、免疫沈降、免疫蛍光、その他

世界の抗ニューロピリン-1抗体市場：地域・国別、2018年-2023年、2024年-2029年
世界の抗ニューロピリン-1抗体市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競合分析】

また、当レポートは主要な市場参加者の分析を提供します。
・主要企業における抗ニューロピリン-1抗体のグローバル売上、2018年-2023年
・主要企業における抗ニューロピリン-1抗体のグローバル売上シェア、2022年
・主要企業における抗ニューロピリン-1抗体のグローバル販売量、2018年-2023年
・主要企業における抗ニューロピリン-1抗体のグローバル販売量シェア、2022年

さらに、当レポートは主要企業のプロファイルを提示します。
LifeSpan BioSciences, Inc、Thermo Fisher、RayBiotech, Inc.、MyBiosource, Inc.、Shanghai Korain Biotech Co., Ltd.、Wuhan Fine Biotech Co., Ltd.、CUSABIO、Boster Biological Technology、Biomatik、Assay Genie、Abbexa、CLOUD-CLONE CORP.、Innovative Research、ZodelBiotec Ltd.

*************************************************************

・調査・分析レポートの概要
抗ニューロピリン-1抗体市場の定義
市場セグメント
世界の抗ニューロピリン-1抗体市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の抗ニューロピリン-1抗体市場規模
世界の抗ニューロピリン-1抗体市場規模：2022年 VS 2029年
世界の抗ニューロピリン-1抗体市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの抗ニューロピリン-1抗体の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の抗ニューロピリン-1抗体製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：モノクローナル抗体、ポリクローナル抗体
抗ニューロピリン-1抗体のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：フローサイトメトリー、ELISA、ウエスタンブロット、免疫沈降、免疫蛍光、その他
抗ニューロピリン-1抗体の用途別グローバル売上・予測

・地域別市場分析
地域別抗ニューロピリン-1抗体市場規模 2022年と2029年
地域別抗ニューロピリン-1抗体売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど）
LifeSpan BioSciences, Inc、Thermo Fisher、RayBiotech, Inc.、MyBiosource, Inc.、Shanghai Korain Biotech Co., Ltd.、Wuhan Fine Biotech Co., Ltd.、CUSABIO、Boster Biological Technology、Biomatik、Assay Genie、Abbexa、CLOUD-CLONE CORP.、Innovative Research、ZodelBiotec Ltd.
...

Anti-Neuropilin-1 Antibody is an unconjugated antibody to Anti-Neuropilin-1.
This report aims to provide a comprehensive presentation of the global market for Anti-Neuropilin-1 Antibody, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anti-Neuropilin-1 Antibody. This report contains market size and forecasts of Anti-Neuropilin-1 Antibody in global, including the following market information:
Global Anti-Neuropilin-1 Antibody Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Anti-Neuropilin-1 Antibody Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Anti-Neuropilin-1 Antibody companies in 2022 (%)
The global Anti-Neuropilin-1 Antibody market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Monoclonal Antibody Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Anti-Neuropilin-1 Antibody include LifeSpan BioSciences, Inc, Thermo Fisher, RayBiotech, Inc., MyBiosource, Inc., Shanghai Korain Biotech Co., Ltd., Wuhan Fine Biotech Co., Ltd., CUSABIO, Boster Biological Technology and Biomatik, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Anti-Neuropilin-1 Antibody manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
[Total Market by Segment]
Global Anti-Neuropilin-1 Antibody Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Anti-Neuropilin-1 Antibody Market Segment Percentages, by Type, 2022 (%)
Monoclonal Antibody
Polyclonal Antibody
Global Anti-Neuropilin-1 Antibody Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Anti-Neuropilin-1 Antibody Market Segment Percentages, by Application, 2022 (%)
Flow Cytometry
ELISA
Western Blot
Immunoprecipitation
Immunofluorescence
Other
Global Anti-Neuropilin-1 Antibody Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Anti-Neuropilin-1 Antibody Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Anti-Neuropilin-1 Antibody revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Anti-Neuropilin-1 Antibody revenues share in global market, 2022 (%)
Key companies Anti-Neuropilin-1 Antibody sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Anti-Neuropilin-1 Antibody sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
LifeSpan BioSciences, Inc
Thermo Fisher
RayBiotech, Inc.
MyBiosource, Inc.
Shanghai Korain Biotech Co., Ltd.
Wuhan Fine Biotech Co., Ltd.
CUSABIO
Boster Biological Technology
Biomatik
Assay Genie
Abbexa
CLOUD-CLONE CORP.
Innovative Research
ZodelBiotec Ltd.
Outline of Major Chapters:
Chapter 1: Introduces the definition of Anti-Neuropilin-1 Antibody, market overview.
Chapter 2: Global Anti-Neuropilin-1 Antibody market size in revenue and volume.
Chapter 3: Detailed analysis of Anti-Neuropilin-1 Antibody manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Anti-Neuropilin-1 Antibody in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Anti-Neuropilin-1 Antibody capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Anti-Neuropilin-1 Antibody Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Anti-Neuropilin-1 Antibody Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Anti-Neuropilin-1 Antibody Overall Market Size
2.1 Global Anti-Neuropilin-1 Antibody Market Size: 2022 VS 2029
2.2 Global Anti-Neuropilin-1 Antibody Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Anti-Neuropilin-1 Antibody Sales: 2018-2029
3 Company Landscape
3.1 Top Anti-Neuropilin-1 Antibody Players in Global Market
3.2 Top Global Anti-Neuropilin-1 Antibody Companies Ranked by Revenue
3.3 Global Anti-Neuropilin-1 Antibody Revenue by Companies
3.4 Global Anti-Neuropilin-1 Antibody Sales by Companies
3.5 Global Anti-Neuropilin-1 Antibody Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Anti-Neuropilin-1 Antibody Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Anti-Neuropilin-1 Antibody Product Type
3.8 Tier 1, Tier 2 and Tier 3 Anti-Neuropilin-1 Antibody Players in Global Market
3.8.1 List of Global Tier 1 Anti-Neuropilin-1 Antibody Companies
3.8.2 List of Global Tier 2 and Tier 3 Anti-Neuropilin-1 Antibody Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Anti-Neuropilin-1 Antibody Market Size Markets, 2022 & 2029
4.1.2 Monoclonal Antibody
4.1.3 Polyclonal Antibody
4.2 By Type – Global Anti-Neuropilin-1 Antibody Revenue & Forecasts
4.2.1 By Type – Global Anti-Neuropilin-1 Antibody Revenue, 2018-2023
4.2.2 By Type – Global Anti-Neuropilin-1 Antibody Revenue, 2024-2029
4.2.3 By Type – Global Anti-Neuropilin-1 Antibody Revenue Market Share, 2018-2029
4.3 By Type – Global Anti-Neuropilin-1 Antibody Sales & Forecasts
4.3.1 By Type – Global Anti-Neuropilin-1 Antibody Sales, 2018-2023
4.3.2 By Type – Global Anti-Neuropilin-1 Antibody Sales, 2024-2029
4.3.3 By Type – Global Anti-Neuropilin-1 Antibody Sales Market Share, 2018-2029
4.4 By Type – Global Anti-Neuropilin-1 Antibody Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Anti-Neuropilin-1 Antibody Market Size, 2022 & 2029
5.1.2 Flow Cytometry
5.1.3 ELISA
5.1.4 Western Blot
5.1.5 Immunoprecipitation
5.1.6 Immunofluorescence
5.1.7 Other
5.2 By Application – Global Anti-Neuropilin-1 Antibody Revenue & Forecasts
5.2.1 By Application – Global Anti-Neuropilin-1 Antibody Revenue, 2018-2023
5.2.2 By Application – Global Anti-Neuropilin-1 Antibody Revenue, 2024-2029
5.2.3 By Application – Global Anti-Neuropilin-1 Antibody Revenue Market Share, 2018-2029
5.3 By Application – Global Anti-Neuropilin-1 Antibody Sales & Forecasts
5.3.1 By Application – Global Anti-Neuropilin-1 Antibody Sales, 2018-2023
5.3.2 By Application – Global Anti-Neuropilin-1 Antibody Sales, 2024-2029
5.3.3 By Application – Global Anti-Neuropilin-1 Antibody Sales Market Share, 2018-2029
5.4 By Application – Global Anti-Neuropilin-1 Antibody Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Anti-Neuropilin-1 Antibody Market Size, 2022 & 2029
6.2 By Region – Global Anti-Neuropilin-1 Antibody Revenue & Forecasts
6.2.1 By Region – Global Anti-Neuropilin-1 Antibody Revenue, 2018-2023
6.2.2 By Region – Global Anti-Neuropilin-1 Antibody Revenue, 2024-2029
6.2.3 By Region – Global Anti-Neuropilin-1 Antibody Revenue Market Share, 2018-2029
6.3 By Region – Global Anti-Neuropilin-1 Antibody Sales & Forecasts
6.3.1 By Region – Global Anti-Neuropilin-1 Antibody Sales, 2018-2023
6.3.2 By Region – Global Anti-Neuropilin-1 Antibody Sales, 2024-2029
6.3.3 By Region – Global Anti-Neuropilin-1 Antibody Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Anti-Neuropilin-1 Antibody Revenue, 2018-2029
6.4.2 By Country – North America Anti-Neuropilin-1 Antibody Sales, 2018-2029
6.4.3 US Anti-Neuropilin-1 Antibody Market Size, 2018-2029
6.4.4 Canada Anti-Neuropilin-1 Antibody Market Size, 2018-2029
6.4.5 Mexico Anti-Neuropilin-1 Antibody Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Anti-Neuropilin-1 Antibody Revenue, 2018-2029
6.5.2 By Country – Europe Anti-Neuropilin-1 Antibody Sales, 2018-2029
6.5.3 Germany Anti-Neuropilin-1 Antibody Market Size, 2018-2029
6.5.4 France Anti-Neuropilin-1 Antibody Market Size, 2018-2029
6.5.5 U.K. Anti-Neuropilin-1 Antibody Market Size, 2018-2029
6.5.6 Italy Anti-Neuropilin-1 Antibody Market Size, 2018-2029
6.5.7 Russia Anti-Neuropilin-1 Antibody Market Size, 2018-2029
6.5.8 Nordic Countries Anti-Neuropilin-1 Antibody Market Size, 2018-2029
6.5.9 Benelux Anti-Neuropilin-1 Antibody Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Anti-Neuropilin-1 Antibody Revenue, 2018-2029
6.6.2 By Region – Asia Anti-Neuropilin-1 Antibody Sales, 2018-2029
6.6.3 China Anti-Neuropilin-1 Antibody Market Size, 2018-2029
6.6.4 Japan Anti-Neuropilin-1 Antibody Market Size, 2018-2029
6.6.5 South Korea Anti-Neuropilin-1 Antibody Market Size, 2018-2029
6.6.6 Southeast Asia Anti-Neuropilin-1 Antibody Market Size, 2018-2029
6.6.7 India Anti-Neuropilin-1 Antibody Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Anti-Neuropilin-1 Antibody Revenue, 2018-2029
6.7.2 By Country – South America Anti-Neuropilin-1 Antibody Sales, 2018-2029
6.7.3 Brazil Anti-Neuropilin-1 Antibody Market Size, 2018-2029
6.7.4 Argentina Anti-Neuropilin-1 Antibody Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Anti-Neuropilin-1 Antibody Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Anti-Neuropilin-1 Antibody Sales, 2018-2029
6.8.3 Turkey Anti-Neuropilin-1 Antibody Market Size, 2018-2029
6.8.4 Israel Anti-Neuropilin-1 Antibody Market Size, 2018-2029
6.8.5 Saudi Arabia Anti-Neuropilin-1 Antibody Market Size, 2018-2029
6.8.6 UAE Anti-Neuropilin-1 Antibody Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 LifeSpan BioSciences, Inc
7.1.1 LifeSpan BioSciences, Inc Company Summary
7.1.2 LifeSpan BioSciences, Inc Business Overview
7.1.3 LifeSpan BioSciences, Inc Anti-Neuropilin-1 Antibody Major Product Offerings
7.1.4 LifeSpan BioSciences, Inc Anti-Neuropilin-1 Antibody Sales and Revenue in Global (2018-2023)
7.1.5 LifeSpan BioSciences, Inc Key News & Latest Developments
7.2 Thermo Fisher
7.2.1 Thermo Fisher Company Summary
7.2.2 Thermo Fisher Business Overview
7.2.3 Thermo Fisher Anti-Neuropilin-1 Antibody Major Product Offerings
7.2.4 Thermo Fisher Anti-Neuropilin-1 Antibody Sales and Revenue in Global (2018-2023)
7.2.5 Thermo Fisher Key News & Latest Developments
7.3 RayBiotech, Inc.
7.3.1 RayBiotech, Inc. Company Summary
7.3.2 RayBiotech, Inc. Business Overview
7.3.3 RayBiotech, Inc. Anti-Neuropilin-1 Antibody Major Product Offerings
7.3.4 RayBiotech, Inc. Anti-Neuropilin-1 Antibody Sales and Revenue in Global (2018-2023)
7.3.5 RayBiotech, Inc. Key News & Latest Developments
7.4 MyBiosource, Inc.
7.4.1 MyBiosource, Inc. Company Summary
7.4.2 MyBiosource, Inc. Business Overview
7.4.3 MyBiosource, Inc. Anti-Neuropilin-1 Antibody Major Product Offerings
7.4.4 MyBiosource, Inc. Anti-Neuropilin-1 Antibody Sales and Revenue in Global (2018-2023)
7.4.5 MyBiosource, Inc. Key News & Latest Developments
7.5 Shanghai Korain Biotech Co., Ltd.
7.5.1 Shanghai Korain Biotech Co., Ltd. Company Summary
7.5.2 Shanghai Korain Biotech Co., Ltd. Business Overview
7.5.3 Shanghai Korain Biotech Co., Ltd. Anti-Neuropilin-1 Antibody Major Product Offerings
7.5.4 Shanghai Korain Biotech Co., Ltd. Anti-Neuropilin-1 Antibody Sales and Revenue in Global (2018-2023)
7.5.5 Shanghai Korain Biotech Co., Ltd. Key News & Latest Developments
7.6 Wuhan Fine Biotech Co., Ltd.
7.6.1 Wuhan Fine Biotech Co., Ltd. Company Summary
7.6.2 Wuhan Fine Biotech Co., Ltd. Business Overview
7.6.3 Wuhan Fine Biotech Co., Ltd. Anti-Neuropilin-1 Antibody Major Product Offerings
7.6.4 Wuhan Fine Biotech Co., Ltd. Anti-Neuropilin-1 Antibody Sales and Revenue in Global (2018-2023)
7.6.5 Wuhan Fine Biotech Co., Ltd. Key News & Latest Developments
7.7 CUSABIO
7.7.1 CUSABIO Company Summary
7.7.2 CUSABIO Business Overview
7.7.3 CUSABIO Anti-Neuropilin-1 Antibody Major Product Offerings
7.7.4 CUSABIO Anti-Neuropilin-1 Antibody Sales and Revenue in Global (2018-2023)
7.7.5 CUSABIO Key News & Latest Developments
7.8 Boster Biological Technology
7.8.1 Boster Biological Technology Company Summary
7.8.2 Boster Biological Technology Business Overview
7.8.3 Boster Biological Technology Anti-Neuropilin-1 Antibody Major Product Offerings
7.8.4 Boster Biological Technology Anti-Neuropilin-1 Antibody Sales and Revenue in Global (2018-2023)
7.8.5 Boster Biological Technology Key News & Latest Developments
7.9 Biomatik
7.9.1 Biomatik Company Summary
7.9.2 Biomatik Business Overview
7.9.3 Biomatik Anti-Neuropilin-1 Antibody Major Product Offerings
7.9.4 Biomatik Anti-Neuropilin-1 Antibody Sales and Revenue in Global (2018-2023)
7.9.5 Biomatik Key News & Latest Developments
7.10 Assay Genie
7.10.1 Assay Genie Company Summary
7.10.2 Assay Genie Business Overview
7.10.3 Assay Genie Anti-Neuropilin-1 Antibody Major Product Offerings
7.10.4 Assay Genie Anti-Neuropilin-1 Antibody Sales and Revenue in Global (2018-2023)
7.10.5 Assay Genie Key News & Latest Developments
7.11 Abbexa
7.11.1 Abbexa Company Summary
7.11.2 Abbexa Anti-Neuropilin-1 Antibody Business Overview
7.11.3 Abbexa Anti-Neuropilin-1 Antibody Major Product Offerings
7.11.4 Abbexa Anti-Neuropilin-1 Antibody Sales and Revenue in Global (2018-2023)
7.11.5 Abbexa Key News & Latest Developments
7.12 CLOUD-CLONE CORP.
7.12.1 CLOUD-CLONE CORP. Company Summary
7.12.2 CLOUD-CLONE CORP. Anti-Neuropilin-1 Antibody Business Overview
7.12.3 CLOUD-CLONE CORP. Anti-Neuropilin-1 Antibody Major Product Offerings
7.12.4 CLOUD-CLONE CORP. Anti-Neuropilin-1 Antibody Sales and Revenue in Global (2018-2023)
7.12.5 CLOUD-CLONE CORP. Key News & Latest Developments
7.13 Innovative Research
7.13.1 Innovative Research Company Summary
7.13.2 Innovative Research Anti-Neuropilin-1 Antibody Business Overview
7.13.3 Innovative Research Anti-Neuropilin-1 Antibody Major Product Offerings
7.13.4 Innovative Research Anti-Neuropilin-1 Antibody Sales and Revenue in Global (2018-2023)
7.13.5 Innovative Research Key News & Latest Developments
7.14 ZodelBiotec Ltd.
7.14.1 ZodelBiotec Ltd. Company Summary
7.14.2 ZodelBiotec Ltd. Business Overview
7.14.3 ZodelBiotec Ltd. Anti-Neuropilin-1 Antibody Major Product Offerings
7.14.4 ZodelBiotec Ltd. Anti-Neuropilin-1 Antibody Sales and Revenue in Global (2018-2023)
7.14.5 ZodelBiotec Ltd. Key News & Latest Developments
8 Global Anti-Neuropilin-1 Antibody Production Capacity, Analysis
8.1 Global Anti-Neuropilin-1 Antibody Production Capacity, 2018-2029
8.2 Anti-Neuropilin-1 Antibody Production Capacity of Key Manufacturers in Global Market
8.3 Global Anti-Neuropilin-1 Antibody Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Anti-Neuropilin-1 Antibody Supply Chain Analysis
10.1 Anti-Neuropilin-1 Antibody Industry Value Chain
10.2 Anti-Neuropilin-1 Antibody Upstream Market
10.3 Anti-Neuropilin-1 Antibody Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Anti-Neuropilin-1 Antibody Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer



❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
★リサーチレポート[ 抗ニューロピリン-1抗体の世界市場見通し2023年-2029年(Anti-Neuropilin-1 Antibody Market, Global Outlook and Forecast 2023-2029)]についてメールでお問い合わせはこちらでお願いします。
◆関連リサーチレポート◆
  • CD74抗体のグローバル市場展望 2023年-2029年：モノクローナル、ポリクローナル
  • 抗CD44抗体のグローバル市場展望 2023年-2029年：モノクローナル、ポリクローナル
  • CD4抗体のグローバル市場展望 2023年-2029年：モノクローナル、ポリクローナル
  • 抗Olig2抗体の世界市場見通し2023年-2029年
  • 抗ネスチン抗体の世界市場見通し2023年-2029年